Australian Clinical Labs Ltd (AU:ACL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
UBS Group AG and its related entities have ceased to be substantial shareholders in Australian Clinical Labs Ltd as of October 24, 2024. This change in shareholding might influence market perceptions and investor interest in the company. Investors may want to monitor Australian Clinical Labs for further developments in its shareholder composition.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.